Beliefs, attitudes and funding of assisted reproductive technology: Public perception of over 6,000 respondents from 6 European countries
Beliefs, attitudes and funding of assisted reproductive technology: Public perception of over 6,000 respondents from 6 European countries
复制标题
DOI：
10.1371/journal.pone.0211150
复制
发表时间：
2019-01-25
期刊：
影响因子：
3.7
通讯作者：
Levy-Toledano, Rachel
中科院分区：
文献类型：
--
作者：
Fauser, Bart C. J. M.;Boivin, Jacky;Levy-Toledano, Rachel
欧洲的生育率是世界上最低的，这可能是由于生物和生活方式的因素。欧洲各地生育治疗的费用和报销情况各不相同，尽管欧洲公民享有广泛的生育护理机会。由于很少有区域研究评估公众对生育治疗的支持，我们进行了欧洲试管婴儿和生育（LIFE）调查，以确定公众对体外受精（IVF）和配子捐赠作为欧洲男性和女性不孕症治疗的看法。方法和发现本次调查通过在线问卷的形式向居住在法国、德国、意大利、西班牙、瑞典或英国的8682名自愿参加在线研究小组的个人分发。调查内容包括确定受访者对试管婴儿及其成功的看法、对公共资金的需求、不同生活方式的现代家庭对试管婴儿的使用以及对配子捐赠的支持。结果按年龄、原籍国、性别和性取向进行分析。共有6110名（占总数的70%）男性和女性参与了调查。在所有受访者中，10%接受过试管婴儿治疗，48%已经考虑或将考虑不孕情况下的试管婴儿。受访者估计试管婴儿的平均成功率为47%，超过一半的受访者认为试管婴儿的可用性会鼓励人们推迟受孕。尽管93%的答复者认为试管婴儿治疗应在一定程度上由公共资助，但大多数人认为继发性不孕症或使用允许推迟生育的生育治疗应由私人资助。受访者认为，公共资助的刺激试管婴儿周期的平均数量应限制在2至3个（平均2.4个）。如果需要，79%的受访者愿意为试管婴儿支付平均5400美元（SIC）的试管婴儿费用。根据受访者，试管婴儿的平均最小和最大年龄分别为29岁和42岁。目前的调查显示，支持卵子和精子捐赠（78%），支持单身女性体外受精（61%）和同性女性伴侣（64%）。在分析每个群体（即性别、年龄、性取向和国家）的结果时，最年轻的年龄组、同性恋者、双性恋者、德国受访者和男性对试管婴儿的总体积极态度和信念以及对公共资金的看法相似。女性对可用性的感知限制更强。总体而言，调查结果显示，在一个在线小组中，受访者对试管婴儿、配子捐赠和支持生育治疗的公共资金持积极态度。这些发现可能会推动患者和处方医生之间探讨试管婴儿治疗的讨论，以及立法者和付款人之间支持为这些程序提供公共资金的讨论。
BackgroundFertility rates in Europe are among the lowest in the world, which may be attributed to both biological and lifestyle factors. Cost and reimbursement of fertility treatments vary across Europe, although its citizens enjoy wide access to fertility care. Since few regional studies evaluating public support for fertility treatment exist, we conducted the Listening IVF and Fertility in Europe (LIFE) survey to ascertain public perception of in vitro fertilization (IVF) and gamete donation as a treatment for infertility among European men and women.Methods and findingsThis survey was distributed via an online questionnaire to 8,682 individuals who were voluntary participants in an online research panel residing in France, Germany, Italy, Spain, Sweden, or the UK. The survey covered items to determine respondents' beliefs regarding IVF and its success, the need for public funding, the use of IVF among modern families with different lifestyles, and the support for gamete donation. Results were analyzed by age, country of origin, sex, and sexual orientation. A total of 6,110 (70% of total) men and women responded. Among all respondents, 10% had undergone IVF treatment and 48% had considered or would consider IVF in case of infertility. Respondents estimated IVF mean success rate to be 47% and over half of respondents believed that availability of IVF would encourage people to delay conception. Although 93% of respondents believed that IVF treatment should be publicly funded to some extent, a majority believed that secondary infertility or use of fertility treatments allowing to delay parenthood should be financed privately. Survey respondents believed that the mean number of stimulated IVF cycles funded publicly should be limited 2 to 3 (average 2.4). 79% of respondents were willing to pay for IVF if needed with a mean amount of 5,400 (SIC) for a child brought to life through IVF. According to respondents, mean minimum and maximum ages for IVF should be 29 and 42 years old, respectively. The current survey showed support for egg and sperm donation (78%), for IVF in single women (61%) and for same-sex female couples (64%). When analyzing the results per group (i.e., sex, age, sexual orientation, and countries), youngest age groups, homosexuals, bisexuals, German respondents, and men had similar overall positive attitudes and beliefs toward IVF and opinions on public funding. Perceived limits to availability were stronger in women.ConclusionOverall, the survey results demonstrate a positive attitude among respondents in an online panel toward IVF, gamete donation, and support for public funding for fertility treatment. These findings could potentially drive discussions between patients and prescribers to explore IVF treatment and among legislators and payers to support public funding for these procedures.